Search

Search Results
Results 1341 - 1350 of 1455 for Rheumatoid factor
  • Genentech's ACTEMRA approved to treat RA
    News - 8 Jan 2010
    Genentech, Inc., a wholly owned member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) approved ACTEMRA® (tocilizumab) for the treatment of adult patients with...
  • Phase 2 study evaluating VBL Therapeutics' lead compound VB-201 initiated
    News - 5 Jan 2010
    VBL Therapeutics today announced the initiation of a Phase 2 efficacy and safety study evaluating lead compound VB-201 for the treatment of patients with psoriasis. VB-201 is poised to be a...
  • Rituxan in combination with chemo improves survival in chronic lymphocytic leukemia
    News - 8 Dec 2008
    Genentech, Inc. and Biogen Idec have announced that two global Phase III studies in chronic lymphocytic leukemia (CLL), CLL8 and REACH, showed Rituxan (rituximab) plus chemotherapy significantly...
  • Celebrex suspension
    News - 19 Dec 2004
    The National Institutes of Health (NIH) announced that it has suspended the use of COX-2 inhibitor celecoxib (Celebrex™ Pfizer, Inc.) for all participants in a large colorectal cancer prevention...
  • What is Chikungunya?
    Health - 6 Aug 2025
    Discover how chikungunya has become a global health concern and explore what science is doing to combat its spread and reduce its burden.
  • DBL Methotrexate Injection
    Drug - 24 Feb 2025
    Consumer Medicine Information (CMI) about DBL Methotrexate Injection intended for persons living in Australia.
  • What Conditions Are Similar to Fibromyalgia?
    Health - 18 Dec 2024
    The multifaceted nature of fibromyalgia presents challenges in diagnosis and management, often coexisting with conditions like hypothyroidism and arthritis.
  • Voydeya
    Drug - 3 Dec 2024
    Consumer Medicine Information (CMI) about Voydeya intended for persons living in Australia.
  • Vancomycin Viatris
    Drug - 19 Sep 2024
    Consumer Medicine Information (CMI) about Vancomycin Viatris intended for persons living in Australia.
  • Vancomycin Alphapharm
    Drug - 19 Sep 2024
    Consumer Medicine Information (CMI) about Vancomycin Alphapharm intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback